Eyepoint Pharmaceuticals Inc (EYPT)
6.50 x 2 7.07 x 10
Post-market by (Cboe BZX)
6.64 -0.14 (-2.06%) 04/29/25 [NASDAQ]
6.50 x 2 7.07 x 10
Post-market 6.35 -0.29 (-4.37%) 16:35 ET
for Tue, Apr 29th, 2025
Results
download Want to compare other data? Select Fields| Symbol | EYPT | UPB | DNA | ||
| Company | Eyepoint Pharmaceuticals Inc | Upstream Bio Inc | Ginkgo Bioworks Hldgs Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | ||
| Open | 6.72 | 8.89 | 8.03 | ||
| High | 6.86 | 9.82 | 8.03 | ||
| Low | 6.47 | 8.55 | 7.36 | ||
| Last | 6.64 | 8.98 | 7.38 | ||
| Change | -0.14 | +0.20 | -0.64 | ||
| % Change | -2.06% | +2.28% | -7.98% | ||
| Volume | 385,500 | 216,900 | 835,600 | ||
| 20-Day Average Volume | 882,025 | 306,965 | 1,477,670 | ||
| Previous Close | 6.78 | 8.78 | 8.02 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 5.58 | 7.73 | 7.17 | ||
| 20-Day Raw Stochastic | 88.35% | 71.64% | 64.50% | ||
| 20-Day Relative Strength | 55.84% | 53.82% | 47.40% | ||
| Weighted Alpha | -54.22 | -52.48 | -80.23 | ||
| Today's Opinion | 56% Sell | N/A | 56% Sell | ||
| Previous Opinion | 56% Sell | N/A | 40% Sell | ||
| Last Month's Opinion | 100% Sell | N/A | 56% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.00% since 04/22/25 | -11.53% since 04/22/25 | -2.12% since 04/22/25 | ||
| Low | 6.06 on 04/25/25 | 7.93 on 04/28/25 | 7.36 on 04/29/25 | ||
| High | 7.00 on 04/23/25 | 10.50 on 04/23/25 | 8.47 on 04/23/25 | ||
| 1-Month | |||||
| %Chg | +13.89% since 03/28/25 | +30.71% since 03/28/25 | +20.59% since 03/28/25 | ||
| Low | 3.91 on 04/09/25 | 5.14 on 04/09/25 | 5.00 on 04/04/25 | ||
| High | 7.00 on 04/23/25 | 10.50 on 04/23/25 | 8.69 on 04/14/25 | ||
| 3-Month | |||||
| %Chg | -14.10% since 01/29/25 | -12.39% since 01/29/25 | -39.76% since 01/29/25 | ||
| Low | 3.91 on 04/09/25 | 5.14 on 04/09/25 | 5.00 on 04/04/25 | ||
| High | 8.68 on 02/05/25 | 11.80 on 01/31/25 | 16.85 on 02/06/25 | ||
| 6-Month | |||||
| %Chg | -42.46% since 10/29/24 | -64.31% since 10/29/24 | -7.87% since 10/29/24 | ||
| Low | 3.91 on 04/09/25 | 5.14 on 04/09/25 | 5.00 on 04/04/25 | ||
| High | 12.50 on 11/07/24 | 29.46 on 11/06/24 | 16.85 on 02/06/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 465,983 | 471,389 | 465,433 | ||
| Shares Outstanding, K | 68,729 | 53,689 | 58,034 | ||
| Annual Sales | 43,270,000 | 2,370,000 | 227,040,000 | ||
| Annual Net Income | -130,870,000 | -62,810,000 | -547,030,000 | ||
| Last Quarter Sales | 11,590,000 | 610,000 | 43,850,000 | ||
| Last Quarter Net Income | -41,400,000 | -15,990,000 | -107,530,000 | ||
| 60-Month Beta | 1.39 | N/A | 1.34 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.64 on 03/05/25 | -6.96 on 11/07/24 | -1.82 on 02/25/25 | ||
| Latest Earnings Date | 05/14/25 | 06/11/25 | 05/08/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||